HEALTH TECHNOLOGY ASSESSMENT FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES FOR CANCER IN EUROPE, US, AND CANADA

被引：0
|
作者：
Stothard, C. [1 ]
Brown, A. [1 ]
Ralston, S. [2 ]
Curry, A. [2 ]
Cork, D. [1 ]
Hollier-Hann, G. [1 ]
机构：
[1] SIRIUS Market Access, Newcastle Upon Tyne, Nbl, England
[2] SIRIUS Market Access, London, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN256
引用
收藏
页码：S468 / S468
页数：1
相关论文
共 50 条
  • [21] Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
    Alsajjan, Roa
    Mason, Warren P.
    CURRENT ONCOLOGY, 2023, 30 (09) : 8501 - 8549
  • [22] Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access
    Mikhael, Joseph
    Fowler, Jessica
    Shah, Nina
    JCO ONCOLOGY PRACTICE, 2022, 18 (12) : 800 - +
  • [23] Advances in Chimeric Antigen Receptor T-Cell Therapies for Solid Tumors
    Baybutt, Trevor R.
    Flickinger, John C., Jr.
    Caparosa, Ellen M.
    Snook, Adam E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 71 - 78
  • [24] Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies
    Nasiri, Fatemeh
    Kozani, Pouya Safarzadeh
    Salem, Faeze
    Kancha, Maral Mahboubi
    Shokoohi, Setareh Dashti
    Kozani, Pooria Safarzadeh
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [25] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives
    Maher, John
    ONCOTARGETS AND THERAPY, 2023, 16 : 515 - 532
  • [26] COST-EFFECTIVENESS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES FOR BLOOD CANCERS: A SYSTEMATIC REVIEW
    Patel, N.
    Farid, S.
    Gomes, M.
    VALUE IN HEALTH, 2023, 26 (06) : S118 - S118
  • [27] Chimeric Antigen Receptor T-cell based cellular therapies for cancer: An introduction and Indian perspective
    Rathod, Reena J.
    Sukumaran, Reghu K.
    Kedia, Neelam
    Kumar, Jeevan
    Nair, Reena
    Chandy, Mammen
    Gandikota, Lakshmikanth
    Radhakrishnan, Vivek Sulekha
    INDIAN JOURNAL OF CANCER, 2024, 61 (02) : 204 - 214
  • [28] Challenges to Chimeric Antigen Receptor (CAR)-T Cell Therapy for Cancer
    Magee, Michael S.
    Snook, Adam E.
    DISCOVERY MEDICINE, 2014, 18 (100) : 265 - 271
  • [29] Predictors of Failures following Chimeric Antigen Receptor T-cell (CAR T) Therapy
    Figura, N.
    Jain, M.
    Sim, A.
    Dean, E.
    Balagurunathan, Y.
    Chavez, J.
    Shah, B.
    Khimani, F.
    Lazaryan, A.
    Davila, M.
    Liu, H.
    Kim, S.
    Locke, F.
    Robinson, T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S311 - S312
  • [30] Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Dhawale, Tejaswini
    Johnson, P. Connor
    Boateng, Kofi
    Barata, Anna
    Traeger, Lara
    Nelson, Ashley M.
    Lavoie, Mitchell W.
    Holmbeck, Katherine
    Choe, Joanna
    Nabily, Anisa
    Tripathi, Astha
    Amonoo, Hermioni L.
    Frigault, Matt
    El-Jawahri, Areej
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 402.e1 - 402.e12
12345